| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/34831541_HAS_TOPIC_C0013227> <https://research.tib.eu/covid-19/entity/34831541_HAS_TOPIC_C0035363> <https://research.tib.eu/covid-19/entity/34831541_HAS_TOPIC_C0037747> <https://research.tib.eu/covid-19/entity/34831541_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/34831541_HAS_TOPIC_C0454662> <https://research.tib.eu/covid-19/entity/34831541_HAS_TOPIC_C0454822> <https://research.tib.eu/covid-19/entity/34831541_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/34831541_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/34831541_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, 50009 Zaragoza, Spain.\', \'Teaching Unit of Preventive Medicine and Public Health, Miguel Servet University Hospital, 50009 Zaragoza, Spain.\', \'Centro Interdipartimentale di Ricerca in Farmacoeconomia e Farmacoutilizzazione (CIRFF), Center of Drug Utilization and Pharmacoeconomics, Department of Pharmacy, University of Naples Federico II, 80131 Naples, Italy.\', \'Health Services Research on Chronic Patients Network (REDISSEC), Institute of Health Carlos III (ISCIII), 28222 Madrid, Spain.\', \'Delicias-Sur Primary Care Health Centre, Aragon Health Service (SALUD), 50009 Zaragoza, Spain.\', \'Drug Utilization Work Group, Spanish Society of Family and Community Medicine (semFYC), 08009 Barcelona, Spain.\', \'Primary Care Pharmacy Service Zaragoza III, Aragon Health Service (SALUD), 50017 Zaragoza, Spain.\', \'Aragon Health Service (SALUD), Miguel Servet University Hospital, 50009 Zaragoza, Spain.\', \'WHO Collaborating Centre for Drug Statistics Methodology, Norwegian Institute of Public Health, 0213 Oslo, Norway.\', \'Department of Drug Statistics, Division of Health Data and Digitalisation, Norwegian Institute of Public Health, 0213 Oslo, Norway.\', \'Division of Cardiac Surgery, AOU San Giovanni di Dio e Ruggi d\'Aragona, 84131 Salerno, Italy.\', \'Infectious Disease of Healthcare Direction, AORN Antonio Cardarelli, 80131 Naples, Italy.\', \'Regional Pharmaceutical Unit, Campania Region, 80143 Naples, Italy.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Aza-Pascual-Salcedo_Mercedes> <https://research.tib.eu/covid-19/entity/Bliek-Bueno_Kevin> <https://research.tib.eu/covid-19/entity/Carmona-P%C3%ADrez_Jon%C3%A1s> <https://research.tib.eu/covid-19/entity/Clerencia-Sierra_Mercedes> <https://research.tib.eu/covid-19/entity/Coscioni_Enrico> <https://research.tib.eu/covid-19/entity/Gimeno-Miguel_Antonio> <https://research.tib.eu/covid-19/entity/Gonz%C3%A1lez-Rubio_Francisca> <https://research.tib.eu/covid-19/entity/Ioakeim-Skoufa_Ignatios> <https://research.tib.eu/covid-19/entity/Menditto_Enrica> <https://research.tib.eu/covid-19/entity/Mucherino_Sara> <https://research.tib.eu/covid-19/entity/Orlando_Valentina> <https://research.tib.eu/covid-19/entity/Perrella_Alessandro> <https://research.tib.eu/covid-19/entity/Poblador-Plou_Beatriz> <https://research.tib.eu/covid-19/entity/Prados-Torres_Alexandra> <https://research.tib.eu/covid-19/entity/Trama_Ugo>
?:doi	1178610.3390/ijerph182211786
?:doi	<https://research.tib.eu/covid-19/entity/1178610.3390/ijerph182211786>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Observational_Study> <https://research.tib.eu/covid-19/entity/Research_Support%2C_Non-U.S._Gov%27t>
?:journal	International journal of environmental research and public health
is ?:pmid of	<https://research.tib.eu/covid-19/entity/34831541>
?:pmid	<https://research.tib.eu/covid-19/entity/34831541>
?:pmid	34831541
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	0.735
?:rankingScore_hIndex	67
?:title	Baseline Drug Treatments as Indicators of Increased Risk of COVID-19 Mortality in Spain and Italy.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Property

Value

is ?:annotates of

?:authorAffiliation

[\'EpiChron Research Group, Aragon Health Sciences Institute (IACS), IIS Aragón, Miguel Servet University Hospital, 50009 Zaragoza, Spain.\', \'Teaching Unit of Preventive Medicine and Public Health, Miguel Servet University Hospital, 50009 Zaragoza, Spain.\', \'Centro Interdipartimentale di Ricerca in Farmacoeconomia e Farmacoutilizzazione (CIRFF), Center of Drug Utilization and Pharmacoeconomics, Department of Pharmacy, University of Naples Federico II, 80131 Naples, Italy.\', \'Health Services Research on Chronic Patients Network (REDISSEC), Institute of Health Carlos III (ISCIII), 28222 Madrid, Spain.\', \'Delicias-Sur Primary Care Health Centre, Aragon Health Service (SALUD), 50009 Zaragoza, Spain.\', \'Drug Utilization Work Group, Spanish Society of Family and Community Medicine (semFYC), 08009 Barcelona, Spain.\', \'Primary Care Pharmacy Service Zaragoza III, Aragon Health Service (SALUD), 50017 Zaragoza, Spain.\', \'Aragon Health Service (SALUD), Miguel Servet University Hospital, 50009 Zaragoza, Spain.\', \'WHO Collaborating Centre for Drug Statistics Methodology, Norwegian Institute of Public Health, 0213 Oslo, Norway.\', \'Department of Drug Statistics, Division of Health Data and Digitalisation, Norwegian Institute of Public Health, 0213 Oslo, Norway.\', \'Division of Cardiac Surgery, AOU San Giovanni di Dio e Ruggi d\'Aragona, 84131 Salerno, Italy.\', \'Infectious Disease of Healthcare Direction, AORN Antonio Cardarelli, 80131 Naples, Italy.\', \'Regional Pharmaceutical Unit, Campania Region, 80143 Naples, Italy.\']

?:citedBy